Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideAntineoplastic AgentsTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationCombined Modality TherapyRecurrenceHematopoiesisNeoplasmsMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteTime FactorsBone Marrow ExaminationTreatment OutcomeRemission InductionImmunosuppressive AgentsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsSurvival AnalysisTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionRetrospective StudiesImmunosuppressionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionAcute DiseaseHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesSevere Combined ImmunodeficiencyColony-Forming Units AssayChimeraHLA AntigensMyelodysplastic SyndromesSurvival RateFollow-Up StudiesLung TransplantationActuarial AnalysisHematologic DiseasesBone DensityCyclosporineLymphocyte TransfusionDisease-Free SurvivalNuclear FamilyCell DifferentiationCarmustineOrgan TransplantationMice, Inbred BALB CPrognosisPancytopeniaGraft vs Tumor EffectFlow CytometryLeukocyte CountCytarabineGraft vs Leukemia EffectCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorEtoposideSpleenBone ResorptionMelphalanLymphomaMultiple MyelomaCells, CulturedBone NeoplasmsFatal OutcomeDrug Resistance, NeoplasmProspective StudiesMice, KnockoutAntibodies, Monoclonal